PHARMACOGNOSTICAL STANDARDIZATION, PHYTOCHEMICAL ANALYSIS AND ANTIOXIDANT AND ANTIDEPRESSANT POTENCY OF IRIS GERMANICA L

Main Article Content

Saeema Farooq
Dr. Prince Ahad Mir Prince Ahad
Mohi-ud-din
Reyaz Hassan Mir
Nimita Manocha
Nishant Kumar
Zulfiqar Ali Bhat

Keywords

Iris germanica,, Genus,, Standardization,, Identification,, Phytochemical Screening

Abstract

Background: The plant species Iris germanica L., belonging to the family Iridiaceae, is a notable collection of approximately 1800 species. It is classified under the genus Iris, which is recognised as one of the largest genera. Objective: This study aims to provide a comprehensive overview of the pharmacognostical studies, phytochemical investigation, and evaluation of antioxidant and antidepressant activity of Iris germanica L. Materials and methods:  The rhizomes of Iris germanica were collected, subjected to shade drying, and subsequently pulverised. The powdered sample was then assessed for pharmacognostic parameters, including macroscopic and microscopic characteristics, physicochemical properties, and phytochemical analysis, utilising established methodologies. The antidepressant efficacy of different hydroalcoholic fractions was assessed using the forced swim test, tail suspension test, and water wheel models. The assessment of the antioxidant activity of fractions was conducted through the utilisation of the DPPH free radical scavenging assay and the reducing power method. Results: The analysis of the hydroalcoholic extract of Iris germanica rhizomes yielded several phytoconstituents, including tannins, flavonoids, terpenoids, and carbohydrates. The findings of the study on antidepressant activity indicated that the ethyl acetate fraction of the hydroalcoholic extract of Iris germanica exhibited significant levels of activity compared to other fractions. The utilisation of this screening procedure holds significant value in determining the presence of various phytoconstituents. Additionally, the observed antidepressant potential of Iris germanica positions it as a promising candidate for the development of herbal antidepressant medications. Furthermore, the extracts exhibit considerable antioxidant capacity. Conclusion: In conclusion, this study provides valuable insights into the microscopic characteristics, proximate analysis, and preliminary phytochemical screening of Iris germanica rhizomes. The data collected from this study can serve as a reference point for quality control measures in the plant under investigation. Additionally, it can be utilised as a medicinal substance for the alleviation of various ailments. Moreover, it can be considered a valuable source of information in the establishment of pharmacognostic standards pertaining to the aspects of quality, purity, identification, and classification. Additionally, the study on antidepressants and antioxidants demonstrated that the extracts exhibit noteworthy potential in terms of both antidepressant and antioxidant properties.

Abstract 326 | Pdf Downloads 232

References

Tasnim, M., et al. Intelligent depression detection and support system: statistical analysis, psychological review and design implication. in 2016 IEEE 18th International Conference on e-Health Networking, Applications and Services (Healthcom). 2016. IEEE.
2. Melville, J.L., et al., Prevalence of comorbid psychiatric illness and its impact on symptom perception, quality of life, and functional status in women with urinary incontinence. American journal of obstetrics and gynecology, 2002. 187(1): p. 80-87.
3. Horwitz, A.V. and J.C. Wakefield, The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. 2007: Oxford University Press.
4. Pitharouli, M.C., et al., Elevated C-reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK Biobank. American Journal of Psychiatry, 2021. 178(6): p. 522-529.
5. Kwon, M., et al., The role of descending inhibitory pathways on chronic pain modulation and clinical implications. Pain Practice, 2014. 14(7): p. 656-667.
6. Horwitz, A.V., J.C. Wakefield, and L. Lorenzo-Luaces, History of depression. The Oxford handbook of mood disorders, 2016: p. 11-23.
7. Newell, J.M. and G.A. MacNeil, Professional burnout, vicarious trauma, secondary traumatic stress, and compassion fatigue. Best practices in mental health, 2010. 6(2): p. 57-68.
8. Bauer, M.S. and L. McBride, Structured group psychotherapy for bipolar disorder: The life goals program. 2003: Springer Publishing Company.
9. Constantino, M.J., et al., The association between patient characteristics and the therapeutic alliance in cognitive-behavioral and interpersonal therapy for bulimia nervosa. Journal of Consulting and Clinical Psychology, 2005. 73(2): p. 203.
10. Ye, Y., The current mechanism and treatment methods for depression. Highlights in Science, Engineering and Technology, 2022. 8: p. 329-337.
11. Sarris, J., et al., Lifestyle medicine for depression. BMC psychiatry, 2014. 14(1): p. 1-13.
12. Soriano, J.B., et al., The burden of disease in Spain: Results from the Global Burden of Disease 2016. Medicina Clínica (English Edition), 2018. 151(5): p. 171-190.
13. Steinegger, E., O. Sticher, and R. Hänsel, Pharmakognosie, Phytopharmazie, 6. Springer Verlag, Berlin Heidelberg New York, S, 1988. 372: p. 696-699.
14. Mir, P.A., M.A. Dar, and G.N. Bader, Pharmacognostical standardization, phytochemical investigation, and anthelminthic activity of Arisaema propinquum Schott rhizomes. Pharmacognosy Research, 2020. 12(2).
15. santé, O.m.d.l., Quality control methods for herbal materials. 2011: World Health Organization.
16. Mukherjee, P.K., Quality control of herbal drugs: an approach to evaluation of botanicals. 2002: Business horizons.
17. Ahad Mir, P., et al., Evaluation of anti-arthritic potential of arisaema propinquum schott rhizomes against complete freund’s adjuvant induced arthritic rats. Ann Pharmacol Pharm. 2020; 5 (2), 2020. 1180.
18. Porsolt, R., A. Bertin, and M. Jalfre, Behavioral despair in mice: a primary screening test for antidepressants. Archives internationales de pharmacodynamie et de therapie, 1977. 229(2): p. 327-336.
19. Zomkowski, A.D.E., et al., Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain research, 2004. 1023(2): p. 253-263.
20. Hsu, L.-C., et al., Antidepressant-like activity of the ethanolic extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the forced swimming test and in the tail suspension test in mice. Evidence-Based Complementary and Alternative Medicine, 2012. 2012.
21. Steru, L., et al., The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology, 1985. 85: p. 367-370.
22. Kumar, B.A., et al., Antidepressant activity of methanolic extract of Amaranthus spinosus. Basic and Clinical Neuroscience, 2014. 5(1): p. 11.
23. Nomura, S., et al., A new behavioral test for antidepressant drugs. European Journal of Pharmacology, 1982. 83(3-4): p. 171-175.
24. Petit-Demouliere, B., F. Chenu, and M. Bourin, Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology, 2005. 177: p. 245-255.
25. Mir, P., et al., Evaluation of antioxidant and anti-inflammatory activity of methanolic and aqueous extract of Arisaema propinquum Schott rhizomes. Journal of Biomedical and Pharmaceuticals Sciences, 2019. 2: p. 120.
26. Kumar, P.S., et al., Antioxidant activity in some selected Indian medicinal plants. African journal of Biotechnology, 2008. 7(12).
27. Braca, A., et al., Morelli. Principles from bauhinia terapotensis. J Nat Prod, 2001. 6: p. 892-5.
28. Dar, M.A., et al., Free radical scavenging activity of methanol aerial extract of Mentha arvensis Linn from Kashmiri Himalaya. World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), 2014. 3(2): p. 2403-2411.